(Q38291127)

English

Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Andrea Anichini

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Marialuisa Sensi

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Dirk Schadendorf

9

object named as

Dirk Schadendorf

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Marilisa Carsana

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Gabrina Tragni

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Gabriella Nicolini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Ilaria Bersani

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Giorgio Parmiani

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Yuan Sheng Sun

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Peter Möller

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

243-253

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11896440%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Human tumor antigens for cancer vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Cell-based vaccination against melanoma--background, preliminary results, and perspective

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Phase 2 trial of vaccination with tyrosinase peptides and granulocyte-macrophage colony-stimulating factor in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Vaccination of melanoma patients with interleukin 4 gene-transduced allogeneic melanoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

T-cell repertoire diversity and clonal expansions in normal and clinical samples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Analysis of TCR usage in human tumors: a new tool for assessing tumor-specific immune responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

In situ T cells in melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Induction of tumor-specific cytotoxic T lymphocytes by immunization with autologous tumor cells and interleukin-2 gene transfected fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

A natural cytotoxic T cell response in a spontaneously regressing human melanoma targets a neoantigen resulting from a somatic point mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillanc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Status of activation of circulating vaccine-elicited CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

In vivo selective expansion of a tumour-specific cytotoxic T-cell clone derived from peripheral blood of a melanoma patient after vaccination with gene-modified autologous tumour cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Increased non-major histocompatibility complex-restricted lytic activity in melanoma patients vaccinated with cytokine gene-transfected autologous tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Quantitation of T-cell receptor frequencies by competitive polymerase chain reaction: dynamics of T-cell clonotype frequencies in an expanding tumor-infiltrating lymphocyte culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

21 January 2018

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T-cell expansion and tumor-specific cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence analysis of the human alpha beta T-cell receptor CDR3 region

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700435

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38291127&oldid=2201525179"